Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Diagnostics as essential tools for containing antibacterial resistance.

Okeke IN, Peeling RW, Goossens H, Auckenthaler R, Olmsted SS, de Lavison JF, Zimmer BL, Perkins MD, Nordqvist K.

Drug Resist Updat. 2011 Apr;14(2):95-106. doi: 10.1016/j.drup.2011.02.002. Epub 2011 Mar 12. Review.

PMID:
21398170
2.
3.

The global need for effective antibiotics-moving towards concerted action.

Cars O, Hedin A, Heddini A.

Drug Resist Updat. 2011 Apr;14(2):68-9. doi: 10.1016/j.drup.2011.02.006. Epub 2011 Apr 1. Review.

PMID:
21444235
4.

Improving the treatment of musculoskeletal infections with molecular diagnostics.

Tarkin IS, Dunman PM, Garvin KL.

Clin Orthop Relat Res. 2005 Aug;(437):83-8. Review.

PMID:
16056030
5.

The global need for effective antibiotics-a summary of plenary presentations.

Alvan G, Edlund C, Heddini A.

Drug Resist Updat. 2011 Apr;14(2):70-6. doi: 10.1016/j.drup.2011.01.007. Epub 2011 Mar 26. Review.

PMID:
21440487
6.

The role of the pharmaceutical industry in meeting the public health threat of antibacterial resistance.

Bergström R.

Drug Resist Updat. 2011 Apr;14(2):77-8. doi: 10.1016/j.drup.2011.01.005. Epub 2011 Apr 13. Review.

PMID:
21493123
7.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
8.

Postgenomic strategies in antibacterial drug discovery.

Brötz-Oesterhelt H, Sass P.

Future Microbiol. 2010 Oct;5(10):1553-79. doi: 10.2217/fmb.10.119. Review.

9.

Effective antibacterials: at what cost? The economics of antibacterial resistance and its control.

White AR; BSAC Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and Development.

J Antimicrob Chemother. 2011 Sep;66(9):1948-53. doi: 10.1093/jac/dkr260. Epub 2011 Jun 23.

PMID:
21700625
10.

Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL.

Nat Rev Drug Discov. 2007 Jan;6(1):29-40. Epub 2006 Dec 8. Review.

PMID:
17159923
11.

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J.

Clin Infect Dis. 2009 Jan 1;48(1):1-12. doi: 10.1086/595011. Review.

PMID:
19035777
13.

Functional genomics in antibacterial drug discovery.

Freiberg C, Brötz-Oesterhelt H.

Drug Discov Today. 2005 Jul 1;10(13):927-35. Review.

PMID:
15993812
14.

Potential impact of rapid diagnostic tests on improving antimicrobial use.

Tenover FC.

Ann N Y Acad Sci. 2010 Dec;1213:70-80. doi: 10.1111/j.1749-6632.2010.05827.x. Epub 2010 Nov 4. Review.

PMID:
21054433
15.

Bacterial resistance--the clinical challenge.

Finch R.

Clin Microbiol Infect. 2002;8 Suppl 3:21-32; discussion 33-5. Review.

16.

Exploiting genomics to discover new antibiotics.

McDevitt D, Rosenberg M.

Trends Microbiol. 2001 Dec;9(12):611-7. Review.

PMID:
11728875
17.

Application of SBDD to the discovery of new antibacterial drugs.

Finn J.

Methods Mol Biol. 2012;841:291-319. doi: 10.1007/978-1-61779-520-6_13. Review.

PMID:
22222458
18.

The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?

Vicente M, Hodgson J, Massidda O, Tonjum T, Henriques-Normark B, Ron EZ.

FEMS Microbiol Rev. 2006 Nov;30(6):841-52. Review.

19.

Challenges of antibacterial discovery revisited.

Gwynn MN, Portnoy A, Rittenhouse SF, Payne DJ.

Ann N Y Acad Sci. 2010 Dec;1213:5-19. doi: 10.1111/j.1749-6632.2010.05828.x. Epub 2010 Nov 8. Review.

PMID:
21058956
20.

Targets and assays for discovering novel antibacterial agents.

Donadio S, Carrano L, Brandi L, Serina S, Soffientini A, Raimondi E, Montanini N, Sosio M, Gualerzi CO.

J Biotechnol. 2002 Nov 13;99(3):175-85. Review.

PMID:
12385707

Supplemental Content

Support Center